Updates in clinical science: Alcohol-related hepatitis.

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Alcohol-related hepatitis (AH) presents significant diagnostic and therapeutic challenges.
• Epidemiology of AH is evolving, influenced by pandemic-related alcohol consumption changes and increased incidence post-bariatric surgery.
• Current management of AH faces unmet needs, driving research into novel approaches.

Purpose of the Study:

• To review recent advancements in the diagnosis and treatment of alcohol-related hepatitis.
• To evaluate novel therapeutic strategies and their outcomes.
• To assess the potential for expanded liver transplantation in severe AH cases.

Main Methods:

• Review of recent literature on alcohol-related hepatitis diagnosis and treatment.
• Analysis of novel therapeutic strategies including fecal microbiota transplantation, IL-1 receptor antagonists, and oxysterols.
• Evaluation of studies on corticosteroid and antibiotic use, and early liver transplantation indications.

Main Results:

• Progress in non-invasive diagnostic methods for AH, reducing reliance on liver biopsy.
• Novel therapeutic trials yielded mixed results but identified promising research avenues.
• Evidence suggests expanding indications for early liver transplantation in severe, corticosteroid-refractory AH patients.

Conclusions:

• Recent developments in AH management have increased optimism for severe cases.
• Non-invasive diagnostics and evolving treatment strategies are improving patient care.
• Further research is needed to optimize novel therapies and transplantation protocols for AH.